Howard Gutman - Net Worth and Insider Trading
Howard Gutman Net Worth
The estimated net worth of Howard Gutman is at least $164 dollars as of 2024-11-13. Howard Gutman is the Director of Algernon Pharmaceuticals Inc and owns about 2,045 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $164. Details can be seen in Howard Gutman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Howard Gutman has not made any transactions after 2022-04-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Howard Gutman
Howard Gutman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Howard Gutman owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Howard Gutman’s form 4 insider trades.
Insider Ownership Summary of Howard Gutman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-06 | Director |
Howard Gutman Latest Holdings Summary
Howard Gutman currently owns a total of 1 stock. Howard Gutman owns 2,045 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of April 6, 2022, with a value of $164.
Latest Holdings of Howard Gutman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-06 | 2,045 | 0.08 | 164 |
Holding Weightings of Howard Gutman
Howard Gutman Form 4 Trading Tracker
According to the SEC Form 4 filings, Howard Gutman has made a total of 1 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 2,045 shares on April 6, 2022, which cost Howard Gutman around $12,822.
Insider Trading History of Howard Gutman
- 1
Howard Gutman Trading Performance
GuruFocus tracks the stock performance after each of Howard Gutman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Howard Gutman is -43.47%. GuruFocus also compares Howard Gutman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Howard Gutman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Howard Gutman's insider trading performs compared to the benchmark.
Performance of Howard Gutman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.09 | | | | | |
| Relative Return to S&P 500(%) | -1.11 | | | | | |
Howard Gutman Ownership Network
Ownership Network List of Howard Gutman
Ownership Network Relation of Howard Gutman
Howard Gutman Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Howard Gutman is the Director of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer James Kinley .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Howard Gutman made no insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN). Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 62,500 shares made by Christopher Moreau , a net purchase of 60,500 shares made by Christopher Scott Bryan , and a net purchase of 12,500 shares made by James Kinley .
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 135,500 shares were bought by its insiders, resulting in a net purchase of 135,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Howard Gutman Mailing Address
Above is the net worth, insider trading, and ownership report for Howard Gutman. Currently GuruFocus does not have mailing address information for Howard Gutman.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
